SOLUTION
At Theremia, we build an AI-powered solution for drug optimization, starting with neurology and psychiatry.
Our Technology
We are pioneering a new approach to precision medicine in neurology and psychiatry by providing deep insights into patient response and treatment optimisation.
Identify subgroups of responders
Our AI-driven models help detect key patient subgroups for whom a drug may be more or less effective, enabling personalized treatment strategies.
Provide pharmacological insights
We provide scientific insights into drug differences in effectiveness and safety across multiple scales (phenotypic, molecular...)
Create optimized version of drugs
We optimize pharmacological parameters for specific subgroups (dosage, galenic form, routes of administration, combinations)
Unique access to over 1 million high-quality individual patient data
Theremia has a unique access to high quality granular and longitudinal patient database and interdisciplinary knowledge
.webp&w=2048&q=75)
Interdisciplinary team expertise multi-scale algorithm validated with practitioners across prospective cohorts
Chemistry
Molecular pharmacology
Modeling
Physiopathology
Neurosciences
Pipeline
We are building a scalable technology to reach the whole CNS diseases
